Farmacosorveglianza degli inibitori selettivi della cicloossigenasi-2: Progetto collaborativo tra i servizi farmaceutici e la medicina generale

Translated title of the contribution: Post-marketing surveillance of cyclooxygenase-2 selective inhibitors: A collaborative study with pharmacists and general practitioners

Caterina Anecchino, Simona Monte, Rita Salotti, Domenica Costantino, Elisa Sasso, Antonella Di Matteo, Marilena Romero

Research output: Contribution to journalArticle

Abstract

Over a very short period of time since their marketing authorisation, COXIBs have become more widely used then traditional NSAIDs. The discussion on the real safety/efficacy of this «new» drug category is however still open. A pilot study has been conducted to assess the feasibility of establishing a prospective cohort of patients exposed to COXIBs, through a network of 22 pharmaceutical units of the NHS each recruiting 10 GPs. Over a period of 6 months, 1962 patients have been recruited and monitored for their clinical course according to a predefined post marketing oriented protocol.

Translated title of the contributionPost-marketing surveillance of cyclooxygenase-2 selective inhibitors: A collaborative study with pharmacists and general practitioners
Original languageItalian
Pages (from-to)187-192
Number of pages6
JournalGiornale Italiano di Farmacia Clinica
Volume16
Issue number4
Publication statusPublished - Oct 2002

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Post-marketing surveillance of cyclooxygenase-2 selective inhibitors: A collaborative study with pharmacists and general practitioners'. Together they form a unique fingerprint.

  • Cite this

    Anecchino, C., Monte, S., Salotti, R., Costantino, D., Sasso, E., Di Matteo, A., & Romero, M. (2002). Farmacosorveglianza degli inibitori selettivi della cicloossigenasi-2: Progetto collaborativo tra i servizi farmaceutici e la medicina generale. Giornale Italiano di Farmacia Clinica, 16(4), 187-192.